Lyra TherapeuticsLYRA
那斯達克 · USD
0
0
(0%)
盤中 01/01 08:00 (UTC+8)
01/01 08:00 (UTC+8)
Lyra TherapeuticsLYRA
0
0
(0%)
財務數據
損益表
- 0.00
- 0.01
- 0.00
- 0.01
- 0.01
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 11.71
- 18.78
- -73.16
- 264.38
- 12.41
- -67.39
- 7.18
- -12.44
- 0.00
- -86.34
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 25 | 183 | 183 | 209 | 195 | 598 | 532 | 146 | 544 | 458 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 25 | 183 | 183 | 209 | 195 | 598 | 532 | 146 | 544 | 458 |
營業費用 | 6,262 | 9,009 | 9,024 | 11,617 | 12,637 | 49,572 | 24,056 | 16,623 | 17,371 | 16,961 |
研發費用 | 4,047 | 5,110 | 4,876 | 6,362 | 5,902 | 13,264 | 18,238 | 12,266 | 12,368 | 10,799 |
推銷及管理費用 | 2,236 | 3,501 | 3,263 | 3,613 | 3,931 | 5,139 | 5,818 | 4,357 | 5,003 | 4,570 |
非經常性項目費用 | -21 | 398 | 885 | 1,642 | 2,804 | 31,169 | - | - | - | 1,592 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -6,237 | -8,826 | -8,841 | -11,408 | -12,442 | -48,974 | -23,524 | -16,477 | -16,827 | -16,503 |
其他收入及費用 | 256 | 1,391 | 298 | 435 | 576 | 855 | 1,086 | 1,338 | 1,192 | 897 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -5,981 | -7,435 | -8,543 | -10,973 | -11,866 | -48,119 | -22,438 | -15,139 | -15,635 | -15,606 |
所得稅 | 3 | 2 | 4 | 6 | 7 | 12 | 14 | 17 | 16 | 12 |
稅後純益 | -5,984 | -7,437 | -8,547 | -10,979 | -11,873 | -48,131 | -22,452 | -15,156 | -15,651 | -15,618 |
基本每股稅後盈餘(元) | -3.38 | -5.51 | -0.13 | -0.16 | -0.18 | -0.74 | -0.35 | - | -0.27 | -0.36 |
稀釋每股稅後盈餘(元) | -2.85 | -5.51 | -0.13 | -0.16 | -0.18 | -0.74 | -0.35 | -0.22 | -0.25 | -0.35 |
基本平均股數(千股) | 1767.00 | 1348.00 | 65757.00 | 65529.00 | 65456.00 | 65459.00 | 64011.00 | - | 56953.00 | 43676.00 |
稀釋平均股數(千股) | 1767.00 | 1348.00 | 65757.00 | 65529.00 | 65456.00 | 65459.00 | 64011.00 | - | 56953.00 | 43676.00 |
還原基本每股稅後盈餘(元) | -3.38 | -5.51 | -6.50 | -8.00 | -9.07 | -36.76 | -17.50 | - | -13.50 | -18.00 |
還原稀釋每股稅後盈餘(元) | -2.85 | -5.51 | -6.50 | -8.05 | -8.94 | -37.00 | -17.50 | -11.00 | -12.50 | -17.50 |
還原基本平均股數(千股) | 1,767 | 1,348 | 1,315 | 1,310 | 1,309 | 1,309 | 1,280 | - | 1,139 | 873 |
還原稀釋平均股數(千股) | 1,767 | 1,348 | 1,315 | 1,310 | 1,309 | 1,309 | 1,280 | - | 1,139 | 873 |
EBITDA(千元) | -5,877 | -7,308 | -8,415 | -11,089 | -12,228 | -48,649 | -23,235 | -16,142 | -16,759 | -16,255 |